Company Filing History:
Years Active: 2002
Title: William Fleming Hoggan Jarrett: Innovator in Papillomavirus Treatment
Introduction
William Fleming Hoggan Jarrett is a notable inventor based in Glasgow, GB. He has made significant contributions to the field of medical research, particularly in the treatment of papillomavirus-related conditions. His innovative work has led to the development of a unique method that utilizes the L2 protein of papillomavirus for therapeutic purposes.
Latest Patents
Jarrett holds a patent for a method of treatment using papillomavirus L2 protein. This patent involves the cloning of the L2 protein of papillomavirus, specifically BPV-2 and BPV-4, as a fusion protein with beta-galactosidase and GST. The research indicates that vaccination of calves with this protein has both a prophylactic effect in tumor prevention and a therapeutic effect in tumor regression. He has 1 patent to his name, showcasing his innovative approach to tackling health issues.
Career Highlights
Jarrett is associated with Cancer Research Campaign Technology Limited, where he continues to advance his research and development efforts. His work has been instrumental in exploring new avenues for cancer treatment, particularly through the use of viral proteins. His dedication to improving health outcomes through scientific innovation is commendable.
Collaborations
Throughout his career, Jarrett has collaborated with esteemed colleagues, including Maria Saveria Campo and Kenneth Thomas Smith. These partnerships have enriched his research and contributed to the advancement of knowledge in the field of cancer treatment.
Conclusion
William Fleming Hoggan Jarrett is a pioneering inventor whose work in papillomavirus treatment has the potential to make a significant impact in the medical field. His innovative methods and collaborations highlight the importance of research in developing effective therapies.